OCC 0.65% 38.8¢ orthocell limited

OCC Trading, page-1666

  1. 765 Posts.
    lightbulb Created with Sketch. 124
    You have to admit this really is a dog of an investment. Im hanging in because i believe remplir has the ability to make the company successful. Striate is going about as good as can be expected, it was never going to be a rocket type product. Very early days in its journey too so need to give it a couple of years to build sales. You cant just come in to the market with a product and expect everyone to jump o board. A lot of options expiring later this year, something like 16m, so the directors certainly would be feeling it too.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.